Citigroup and Royal Bank of Canada are involved in stock transactions and analyst target price changes, alongside required SEC filings.
3 reports, 2 independent
Updated Aug 15
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup and Royal Bank of Canada are involved in stock transactions and analyst target price changes, alongside required SEC filings.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Dexcom stock received a raised price objective and rating restatement from analysts, accompanied by SEC filings.Sub-event
- Financial institutions, including Citigroup and RBC, filed 13F reports and adjusted analyst ratings with the SEC.Sub-event
Citigroup's analyst target price increased while share ownership disclosures were filed, involving RBC and the SEC.1 source
Keep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Royal Bank of Canada
financial institution in Canada
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Analyst raised price target and gave outperform rating for Aramark on August 19, 2026.
- Analyst coverage for Vornado Realty Trust resulted in rating changes and price target adjustments from firms including Citigroup, Morgan Stanley, and Truist Financial.
- Analyst upgraded rating and set price target for Pound Medical, and Royal Bank of Canada increased its share holdings.
- Bank of America and Bank of New York are involved in market activities, including analyst target price increases and required 13F filings with the SEC.
- RBC raised its target price for Howmet Aerospace, while Citigroup reiterated a 'buy' rating on the shares.